Anti-PD-L1 mediating tumor-targeted codelivery of liposomal irinotecan/JQ1 for chemo-immunotherapy
Zhidi He, Meng Zhang, Yonghui Wang, Yang He, Hai-rui Wang, Binfan Chen, Bin Tu, Siqi Zhu, Yongzhuo Huang
Topics & Concepts
Immune systemTumor microenvironmentImmunotherapyMedicineImmunogenic cell deathFOXP3Cancer researchIrinotecanImmune checkpointColorectal cancerCD8ImmunologyImmunityCancerInternal medicineCancer Immunotherapy and BiomarkersImmunotherapy and Immune ResponsesImmune cells in cancer